Stan Lambert received an endorsement from Texas Governor Greg Abbott on September 20, just seven weeks before Election Day.

Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per ...

The fragility of the infant formula market is being tested again — this time by legal fights over safety labeling. The big ...

But how about Big Formula? Infant formula is a billion-dollar industry with an insular market. Only a handful of ...

The most recent trading session ended with Abbott (ABT) standing at $117.63, reflecting a +1.06% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a gain ...

Because the Connecticut lawsuit is against health-care providers, it differs from the St. Louis case, which is against Abbott Laboratories, the maker of a formula fed to a baby who suffered brain ...

A lawsuit against Yale New Haven Hospital and Yale University, accusing them of wrongful death for giving a premature baby ...

Inflated jury verdicts in the first two preterm infant formula cases tried in the country have raised significant concerns for manufacturers and ...

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant which was at center of a nationwide formula shortage in 2022. Abbott is recalling several of its ready ...

The most recent trading session ended with Abbott (ABT) standing at $114.66 ... Heading into today, shares of the maker of infant formula, medical devices and drugs had gained 4.27% over the ...

Despite complex regulations for infant formula, contamination in production and supply chain issues at Abbott Nutrition created a dangerous shortage in 2022. The nationwide shortage affected ...

Abbott (ABT) ended the recent trading session ... Coming into today, shares of the maker of infant formula, medical devices and drugs had gained 7.39% in the past month. In that same time, the ...